Lifco Ab header image

Lifco Ab

LIFCO B

Equity

ISIN SE0015949201 / Valor 111355378

NASDAQ Nordic Exchange Stockholm, Equities (2025-11-17)
SEK 348.00-1.53%

Lifco Ab
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Lifco Ab is a company that provides a secure environment for small and medium-sized businesses. The company's main business concept is to acquire and enhance market-leading niche businesses that have the potential for sustainable earnings growth and strong cash flows. Lifco operates with a long-term perspective on its holdings, prioritizing profitability and maintaining a decentralized organizational structure. The company has three main business areas: Dental, Demolition & Tools, and Systems Solutions, with a presence in 31 countries through its 233 operating companies. In 2023, Lifco reported an EBITA margin of 23.2% on net sales of SEK 24.4 billion.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (12.11.2025):

Lifco Ab’s Q4 2024 financial results highlight a robust performance driven by the company’s diversified portfolio and long‐term strategic focus. The group reported net sales of SEK 26.1 billion and an EBITA margin of 22.6%, underlining a stable earnings performance while continuing to support sustainable growth across its Dental, Demolition & Tools, and Systems Solutions business areas.

Strong EBITA Performance

Lifco Ab delivered an EBITA margin of 22.6% in Q4 2024, reflecting strong operational efficiency and profitability.

Robust Net Sales

The company achieved net sales of SEK 26.1 billion during Q4 2024, showcasing its ability to generate considerable revenue across diverse markets.

Global Diversification

By the end of 2024, Lifco Ab’s group comprised 257 operating companies in 34 countries, emphasizing its broad international presence and diversified operational base.

Strategic Long-Term Focus

Lifco Ab’s commitment to acquiring and developing market-leading niche businesses is reinforced by its emphasis on long-term profitability and decentralized management, which is key to its resilient financial results.

Summarized from source with an LLMView Source

Key figures

9.64%1Y
94.4%3Y
162%5Y

Performance

27.0%1Y
26.5%3Y
30.8%5Y

Volatility

Market cap

15539 M

Market cap (USD)

Daily traded volume (Shares)

232,467

Daily traded volume (Shares)

1 day high/low

323.6 / 319.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bio-Rad Laboratories, Inc. Class B
Bio-Rad Laboratories, Inc. Class B Bio-Rad Laboratories, Inc. Class B Valor: 912794
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 310.70
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.81%USD 88.40
Inspire Medical Systems Inc
Inspire Medical Systems Inc Inspire Medical Systems Inc Valor: 41329373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.71%USD 84.87
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.75%USD 0.54
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.14%USD 17.55
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.71%EUR 15.54
STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 257.01
Perrigo Company PLC
Perrigo Company PLC Perrigo Company PLC Valor: 22008864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%USD 13.56
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.42%USD 3.87
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%USD 25.08